HCM
HUTCHMED
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · HK
$13.67
−1.09%Next report
Analyst consensus
- Next report date
- Mar 4, 2027
- EPS estimate
- $0.21
- Revenue estimate
- $329.1M
Latest reported
- Last report date
- Jul 30, 2026
- EPS actual
- $0.05
- EPS estimate
- $0.14
- Revenue actual
- $278.3M
- Revenue estimate
- $304.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +29.2%
- Revenue beats (12Q)
- 1
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $16
- PT range
- $14 – $17
- Analysts
- 2
1 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 30, 2026 | $0.14 | $0.05 | Miss -68.28% | $278.3M |
| Aug 7, 2025 | $1.46 | $1.30 | Miss -10.96% | $138.8M |
| Mar 19, 2025 | -$0.09 | $0.01 | Beat 107.59% | $162.3M |
| Sep 30, 2024 | — | $0.01 | — | $162.3M |
| Mar 19, 2024 | — | $0.01 | — | $152.8M |
| Feb 28, 2023 | -$1.02 | -$0.12 | Beat 88.52% | $112.2M |
| Jul 28, 2021 | -$0.37 | -$0.11 | Beat 71.53% | $75.8M |
| Jul 30, 2020 | -$0.27 | -$0.05 | Beat 81.90% | $55.2M |
| Mar 31, 2020 | — | -$0.02 | — | $51.6M |
| Mar 31, 2019 | — | -$0.03 | — | $52.2M |
| Sep 30, 2018 | — | -$0.04 | — | $58.8M |
| Mar 31, 2018 | — | -$0.02 | — | $52.3M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 4, 2027